Asymptomatic ALCAPA with Preserved Myocardial Function in a 3-Year-Old Child
C Leclercq1, F Kaladji2, J P Vallée3
1Pediatric Cardiology Unit, University Hospital of Geneva, Geneva, Switzerland. Charlotte.Leclercq@hug.ch.
Pediatric Cardiology
|September 8, 2025
Summary
Anomalous left coronary artery from the pulmonary artery (ALCAPA) is rare. This case study highlights a 3-year-old girl with ALCAPA, showing extensive collaterals and preserved heart function, suggesting a less severe clinical course.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Disease
- Cardiovascular Surgery
Background:
- Anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) is a rare congenital anomaly with typically severe infantile presentation.
- Untreated ALCAPA can lead to left ventricular ischemia, cardiogenic shock, and high mortality rates.
- The typical presentation contrasts with atypical, less severe clinical courses observed in some cases.
Purpose of the Study:
- To report a rare case of ALCAPA in a 3-year-old girl.
- To describe the specific cardiovascular findings, including collateral circulation and left ventricular function.
- To discuss the implications of these findings on the clinical course and management of ALCAPA.
Main Methods:
- Case report of a 3-year-old female patient.
- Diagnostic evaluation including echocardiography and potentially other imaging modalities (details not provided in abstract).
- Assessment of coronary artery anomalies, collateral pathways, and ventricular function.
Main Results:
- Diagnosis of anomalous left coronary artery from the pulmonary artery (ALCAPA) in a 3-year-old girl.
- Identification of extensive right-to-left collateral vessels.
- Preserved left ventricular function and minimal myocardial injury despite the anomaly.
Conclusions:
- This case demonstrates an atypical presentation of ALCAPA with a milder clinical course.
- Extensive collateralization may play a crucial role in maintaining myocardial perfusion and function.
- Highlights the importance of considering varied presentations of ALCAPA in pediatric cardiology.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
416
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
416
Cardiomyopathy II: Dilated Cardiomyopathy
480
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
480
Cardiomyopathy V: Interprofessional Care
343
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
343
Mitral Stenosis II: Clinical features and Diagnostic Tests
223
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
223
Acute Coronary Syndrome III: Diagnostic Studies
219
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
219
Cardiomyopathy IV: Restrictive Cardiomyopathy
472
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
472


